Cargando…

Inactivation of SARS-CoV-2 in All Blood Components Using Amotosalen/Ultraviolet A Light and Amustaline/Glutathione Pathogen Reduction Technologies

No cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transfusion-transmitted infections (TTI) have been reported. The detection of viral RNA in peripheral blood from infected patients and blood components from infected asymptomatic blood donors is, however, concerning. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santa Maria, Felicia, Huang, Yan-Jang S., Vanlandingham, Dana L., Bringmann, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147860/ https://www.ncbi.nlm.nih.gov/pubmed/35631042 http://dx.doi.org/10.3390/pathogens11050521

Ejemplares similares

Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen‐reduction technology
por: Girard, Yvette A., et al.
Publicado: (2020)

Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction
por: Sow, Cissé, et al.
Publicado: (2022)

Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light
por: Lanteri, Marion C., et al.
Publicado: (2020)

Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technology
por: Sow, Cissé, et al.
Publicado: (2020)

Pathogen inactivation treatment of triple‐dose apheresis platelets with amotosalen and ultraviolet a light
por: Infanti, Laura, et al.
Publicado: (2022)

Clinical impact of amotosalen‐ultraviolet A pathogen‐inactivated platelets stored for up to 7 days
por: Infanti, Laura, et al.
Publicado: (2019)

Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia
por: Aydinok, Yesim, et al.
Publicado: (2019)

Preclinical safety assessment of pathogen reduced red blood cells treated with amustaline and glutathione
por: North, Anne K., et al.
Publicado: (2020)

Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance
por: Stivala, Simona, et al.
Publicado: (2017)

Assessment of dengue virus inactivation in random donor platelets using amotosalen and ultraviolet A illumination
por: Kumar, Ankit, et al.
Publicado: (2022)

Protein Concentrations in Stored Pooled Platelet Concentrates Treated with Pathogen Inactivation by Amotosalen Plus Ultraviolet a Illumination
por: Arnason, Niels Arni, et al.
Publicado: (2022)

Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in human plasma
por: Azhar, Esam I., et al.
Publicado: (2020)

Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light
por: Hindawi, S.I., et al.
Publicado: (2022)

Plasma pooling in combination with amotosalen/UVA pathogen inactivation to increase standardisation and safety of therapeutic plasma units
por: Bubinski, Michal, et al.
Publicado: (2021)

Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment
por: Bagri, Anil, et al.
Publicado: (2022)

Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology
por: Cognasse, Fabrice, et al.
Publicado: (2022)

Evaluation of amotosalen and UVA pathogen‐reduced apheresis platelets after 7‐day storage
por: Cancelas, Jose A., et al.
Publicado: (2022)

THE ULTRAVIOLET LIGHT AND PHOTOSENSITIZED INACTIVATION OF TOBACCO MOSAIC VIRUS
por: Oster, Gerald, et al.
Publicado: (1950)

Ultraviolet-Based Pathogen Inactivation Systems: Untangling the Molecular Targets Activated in Platelets
por: Schubert, Peter, et al.
Publicado: (2018)

Effects of amotosalen treatment on human platelet lysate bioactivity: A proof-of-concept study
por: Christensen, Christian, et al.
Publicado: (2020)

Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light
por: Gracheva, A. V., et al.
Publicado: (2022)

Ultraviolet A and Ultraviolet C Light-Induced Reduction of Surface Hydrocarbons on Titanium Implants
por: Naauman, Zaheer, et al.
Publicado: (2019)

A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen–UVA photochemical treatment
por: Knutson, F, et al.
Publicado: (2015)

Profils d’anticorps dans le plasma de convalescent COVID-19 traité pour traitement de réduction des agents pathogènes par Amotosalen/UVA
por: Corash, Laurence, et al.
Publicado: (2021)

Ultraviolet Light Fights New Virus
por: Mackenzie, Dana
Publicado: (2020)

RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity
por: Green, Alex B., et al.
Publicado: (2023)

Demonstration of the protective effects of fluorescent proteins in baculoviruses exposed to ultraviolet light inactivation
por: Mcintosh, A. H., et al.
Publicado: (2004)

Predicting Inactivation of Bacillus subtilis Spores Exposed to Broadband and Solar Ultraviolet Light
por: Handler, F.A.
Publicado: (2019)

Bacterial Spore Inactivation in Orange Juice and Orange Peel by Ultraviolet-C Light
por: Colás-Medà, Pilar, et al.
Publicado: (2021)

Efficacy of pulsed-xenon ultraviolet light on reduction of Mycobacterium fortuitum
por: Huber, Thomas W, et al.
Publicado: (2020)

The Effects of Ultraviolet Light and Riboflavin on Inactivation of Viruses and the Quality of Platelet Concentrates at Laboratory Scale
por: Mirshafiee, Hamideh, et al.
Publicado: (2015)

Efficacy of 265-nm ultraviolet light in inactivating infectious SARS-CoV-2
por: Shimoda, Hiroshi, et al.
Publicado: (2021)

Rapid inactivation of Dabie bandavirus (SFTSV) by irradiation with deep‐ultraviolet light‐emitting diode
por: Kaneko, Chiho, et al.
Publicado: (2022)

Wavelength dependence of ultraviolet light inactivation for SARS-CoV-2 omicron variants
por: Fujimoto, Nahoko, et al.
Publicado: (2023)

The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates
por: Nebie, Ouada, et al.
Publicado: (2019)

Preparation and Storage of Cryoprecipitate Derived from Amotosalen and UVA-Treated Apheresis Plasma and Assessment of In Vitro Quality Parameters
por: Kovacic Krizanic, Katarina, et al.
Publicado: (2022)

Effectiveness of germicidal ultraviolet light to inactivate coronaviruses on personal protective equipment to reduce nosocomial transmission
por: Camargo, Carolina, et al.
Publicado: (2022)

Effect of Ultraviolet Light C (UV-C) Radiation Generated by Semiconductor Light Sources on Human Beta-Coronaviruses’ Inactivation
por: Sobotka, Piotr, et al.
Publicado: (2022)

Aluminum plasmonic nanoshielding in ultraviolet inactivation of bacteria
por: Kunz, Jeremy N., et al.
Publicado: (2017)

Inactivation of Escherichia coli O157:H7 and Listeria monocytogenes in biofilms by pulsed ultraviolet light
por: Montgomery, Nedra L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5051c673dirmi97qucdbqcs3fd